Showing results (691-700 of 757) with videos related to
Sort By:
Pageof 76
The American Journal of Cardiology|December 17, 2008
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemiaJean-Charles Fruchart, Frank Sacks, Michel P Hermans, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 11, 2020
Identifying critically important cardiovascular outcomes for trials in hemodialysis: an international survey with patients, caregivers and health professionalsEmma O'Lone, Martin Howell, Andrea K Viecelli, et al.Kidney International|September 26, 2020
Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across EuropeKitty J Jager, Anneke Kramer, Nicholas C Chesnaye, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 5, 2020
Funding kidney research as a public health priority: challenges and opportunitiesCarmine Zoccali, Raymond Vanholder, Carsten A Wagner, et al.Diabetes & Vascular Disease Research|October 30, 2008
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patientJean-Charles Fruchart, Frank M Sacks, Michel P Hermans, et al.Journal of the American College of Cardiology|June 16, 2018
Cardiovascular Outcomes Reported in Hemodialysis TrialsEmma O'Lone, Andrea K Viecelli, Jonathan C Craig, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 1, 2015
Mortality from infections and malignancies in patients treated with renal replacement therapy: data from the ERA-EDTA registryJudith L Vogelzang, Karlijn J van Stralen, Marlies Noordzij, et al.Kidney International|June 20, 2024
A meta-analysis of randomized controlled clinical trials for implications of acute treatment effects on glomerular filtration rate for long-term kidney protectionHiddo J L Heerspink, Devin Eddington, Juhi Chaudhari, et al.Wiener Klinische Wochenschrift|March 12, 2014
New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular riskGerald Klose, Frank Ulrich Beil, Hans Dieplinger, et al.The New England Journal of Medicine|November 5, 2021
Daprodustat for the Treatment of Anemia in Patients Undergoing DialysisAjay K Singh, Kevin Carroll, Vlado Perkovic, et al.Pageof 76